Filter
1470
Filtered Results: 1470
Text search:
pharmaceutical
situation
Featured
Recommendations
141
New Publications
402
Language
Document type
No document type
790
Studies & Reports
263
Guidelines
223
Strategic & Response Plan
68
Manuals
58
Fact sheets
22
Training Material
18
Situation Updates
17
Resource Platforms
5
Infographics
4
Brochures
2
Countries / Regions
Ethiopia
71
Kenya
62
India
58
Global
41
Western and Central Europe
38
South Africa
38
Nigeria
34
Uganda
33
Sierra Leone
32
Liberia
29
Ghana
26
Tanzania
22
Ukraine
20
Malawi
20
Nepal
19
Namibia
19
Latin America and the Carribbean
18
Bangladesh
18
Zambia
18
Rwanda
17
Syria
16
Philippines
16
Africa
15
Eastern Europe
15
South–East Asia Region
14
Cambodia
13
Congo, Democratic Republic of
13
Lesotho
12
Indonesia
12
Zimbabwe
11
Germany
11
Myanmar / Burma
11
Cameroon
8
Venezuela
7
West and Central Africa
7
Eastern Europe and Central Asia
7
Botswana
7
South Sudan
7
Thailand
6
Senegal
6
Asia
6
Albania
5
Burkina Faso
5
Guinea
5
Haiti
5
Vietnam
5
Eswatini/ Swaziland
5
Benin
4
Chile
4
Laos
4
Middle East and North Africa
4
Western Pacific Region
4
East and Southern Africa
4
Papua New Guinea
4
Pakistan
4
China
3
Fiji
3
Mozambique
3
Jordan
3
Brazil
3
Egypt
3
Sudan
3
Mali
3
North Macedonia
2
Peru
2
USA
2
Lithuania
2
Jamaica
2
Lebanon
2
Moldova
2
Russia
2
Central African Republic
2
Iraq
2
Madagascar
2
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
Serbia
1
Iran
1
Kyrgyzstan
1
Niger
1
Afghanistan
1
Bulgaria
1
Ireland
1
Paraguay
1
North America
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
France
1
Maldives
1
United Kingdom
1
Spain
1
Argentina
1
Yemen
1
Romania
1
Palestine
1
Georgia
1
Chad
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
646
Clinical Guidelines
82
Public Health
70
Key Resources
64
Women & Child Health
34
Pharmacy & Technologies
18
Capacity Building
14
Annual Report MEDBOX
2
Toolboxes
AMR
157
COVID-19
151
Pharmacy
102
Mental Health
96
TB
64
HIV
54
Rapid Response
50
Conflict
33
Ebola
30
Planetary Health
29
Global Health Education
28
Caregiver
27
NCDs
23
NTDs
21
Health Financing Toolbox
16
Specific Hazards
11
Natural Hazards
9
Polio
9
Refugee
8
Disability
7
Zika
3
Cholera
2
Health Financing
2
South Sudan
1
Social Ethics
1
Contact tracing is a key component of the COVID-19 response, particularly as societies begin to lift non-pharmaceutical interventions. However, it is a time-consuming and resource-intensive effort that depends on a trained and motivated workforce. Emergent digital contact tracing and quarantine (...
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
This Guidance Document provides practical assistance to Country Offices scaling up programmes to manage SAM in young children. It outlines a step-by-step process through which countries can analyse their current situation, identify barriers and bottlenecks through the MoRES approach, and plan action...
This research paper uses the Health Resources and services Availability Mapping System (HeRAMS) database to develop two composite indices – one for health centres and one for hospitals – in order to analyse and assess the health facilities’ performance across time and to evaluate the di...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef...
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and Pharmaceu...
Sudan recorded the first COVID-19 case on 13 March 2020 and, at the beginning of July, the Federal Ministry of Health had confirmed that nearly 10,000 people had contracted the virus, including over 600 who died from the disease across the country. Although more than 70 per cent of the confirmed cas...
Bioethics - Medical, Ethical and Legal Perspectives
There’s evidence that implementing the four medical ethics principles may be challenging especially in low income country contexts with extreme resource scarcity and limited capacity to facilitate deliberations on the different ethical dilemmas....
The report identifies major global gaps in WASH services: one third of health care facilities do not have what is needed to clean hands where care is provided; one in four facilities have no water services, and 10% have no sanitation services. This means that 1.8 billion people use facilities that l...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
UNCTAD has prepared a rapid assessment of the impact of war in Ukraine on trade and development, and interrelated issues in the areas of finance, technology, investment and sustainable development.
The results confirm a rapidly worsening outlook for the world economy, underpinned by rising food, fu...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
